NCT03417765 2024-10-24
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
VectivBio AG
Phase 1/2 Withdrawn
Clinical Trials
8 trialsNCT02990468 2023-03-15
BMX-HN
BioMimetix JV, LLC
Phase 1/2 Completed
NCT02300727 2019-05-31
Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy
Aurora BayCare Medical Center
Phase 1/2 Terminated
NCT02630004 2018-03-01
MUCOMEL
Spherium Biomed
Phase 1/2 Completed
NCT00626639 2017-06-21
A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy
Swedish Orphan Biovitrum
Phase 1/2 Completed
NCT02575313 2015-10-14
The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer
Providence Health & Services
Phase 1/2 Terminated
NCT00727831 2014-01-27
Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
University College, London
Phase 1/2 Completed
NCT01732393 2012-12-05
Effect of Quercetin in Prevention and Treatment of Oral Mucositis
Mashhad University of Medical Sciences
Phase 1/2 Completed